Sign in
Taking people in United StatesNo phase

Mindfulness Texting for Medication Adherence and Chronic Pain Management

Key facts

Who runs it
University of New Mexico
Where
Albuquerque, United StatesSee the site
Trial code
Status
Recruiting
People taking part
60 people, planned
Started
23 Apr 2025
Expected to end
Oct 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Mindfulness text messages
Record updated
17 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Age 18 years or older
  • Reside in the United States
  • Own or have access to a mobile phone capable of sending and receiving text messages
  • Have reliable internet access to complete study surveys
  • Be willing and able to comply with all study procedures and remain available for the duration of the study
  • Be interested in receiving medication reminders and mindfulness text messages
  • Be within 2 months of initiating or restarting methadone or buprenorphine treatment for opioid use
  • Report chronic pain (pain lasting at least 3 months)
  • Live in the United States

Who cannot take part

  • None

Where in United States

  • University of New MexicoAlbuquerque, United StatesContact: Frank Schwebel, PhDTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to examine the effects of reminder and mindfulness text messages based on integrated Acceptance and Commitment Therapy and Mindfulness Based Relapse Prevention (ACT+MBRP) on medication adherence and managing craving, pain, mindfulness, and withdrawal symptoms in people taking medications for opioid use disorder and with chronic pain through assessment questions collected six times daily during the course of treatment. The main questions it aims to answer are:

Read full original descriptionShow less

1. Do daily medication reminder text messages increase medication adherence for people taking medications for opioid use disorder? 2. To what extent do people engage with the daily mindfulness messages? 3. Do participants receiving a structured curriculum of mindfulness messages delivered twice daily differ from those receiving randomly selected mindfulness messages delivered four times daily in engagement with the intervention? 4. How do the two mindfulness text messaging interventions differ in their effects on intervention engagement, craving, pain, mindfulness, and withdrawal symptoms?

Participants will:

1. Receive daily medication reminder text messages for 12 weeks (i.e., 3 months) 2. Receive either 2 or 4 mindfulness messages per day for 6 weeks 3. Answer brief assessment questions six times per day during the 6-week mindfulness text messaging period 4. Complete questionnaires at enrollment (baseline), once each week during the 6-week mindfulness text messaging period (6 total), immediately after the 6-week mindfulness text messaging period (post-treatment), and 6 weeks after the mindfulness text messaging period ends (follow-up)

The 2 groups in the trial

  • Mindfulness curriculumTreatment being tested

    Participants in this condition receive two mindfulness messages per day at random times as part of a curriculum based on the ACT+MBRP treatment manual.

    Treatment: Mindfulness text messages

  • Random mindfulness messagesTreatment being tested

    Participants in this condition receive four random mindfulness messages per day at random times from the complete bank of mindfulness messages developed based on the Monitoring and Acceptance Theory of mindfulness.

    Treatment: Mindfulness text messages

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Integrating Mindfulness and mHealth Approaches for Treating Opioid Use Disorder and Chronic Pain
Record updated
17 July 2026